|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-4-13
|
|
pubmed:abstractText |
Cellular hypertrophy is an early, important pathological feature of renal diseases such as diabetic nephropathy and remnant kidney. Recent studies have demonstrated that angiotensin II (AngII) plays a key role in mediating cell hypertrophy. The aim of our work was to explore the role of connective tissue growth factor (CTGF) in mediating AngII-induced tubular cell hypertrophy in vivoandin vitro.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/CTGF protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Connective Tissue Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Ctgf protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Immediate-Early Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/irbesartan
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1660-2129
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
2006 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e16-26
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:16374037-Angiotensin II,
pubmed-meshheading:16374037-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:16374037-Animals,
pubmed-meshheading:16374037-Biphenyl Compounds,
pubmed-meshheading:16374037-Cell Cycle,
pubmed-meshheading:16374037-Cell Line,
pubmed-meshheading:16374037-Cells, Cultured,
pubmed-meshheading:16374037-Connective Tissue Growth Factor,
pubmed-meshheading:16374037-Diabetes Mellitus, Experimental,
pubmed-meshheading:16374037-Humans,
pubmed-meshheading:16374037-Hypertrophy,
pubmed-meshheading:16374037-Immediate-Early Proteins,
pubmed-meshheading:16374037-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:16374037-Kidney,
pubmed-meshheading:16374037-Kidney Tubules, Proximal,
pubmed-meshheading:16374037-Male,
pubmed-meshheading:16374037-Rats,
pubmed-meshheading:16374037-Rats, Sprague-Dawley,
pubmed-meshheading:16374037-Reference Values,
pubmed-meshheading:16374037-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16374037-Tetrazoles
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells.
|
|
pubmed:affiliation |
Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, China. liubc64@yahoo.com.cn
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
